You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
|
|---|---|
| Published in |
Journal of Hematology & Oncology, July 2015
|
| DOI | 10.1186/s13045-015-0192-7 |
| Pubmed ID | |
| Authors |
Sandrine Degryse, Jan Cools |
| Abstract |
Recent studies of acute lymphoblastic leukemia have identified activating mutations in components of the interleukin-7 receptor complex (IL7R, JAK1, and JAK3). It will be of interest to investigate both JAK1 and JAK3 kinase inhibitors as targeted agents for these leukemias. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 62 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 26% |
| Student > Master | 11 | 18% |
| Student > Ph. D. Student | 6 | 10% |
| Student > Bachelor | 5 | 8% |
| Other | 3 | 5% |
| Other | 7 | 11% |
| Unknown | 14 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 18 | 29% |
| Agricultural and Biological Sciences | 11 | 18% |
| Medicine and Dentistry | 9 | 15% |
| Immunology and Microbiology | 4 | 6% |
| Materials Science | 2 | 3% |
| Other | 1 | 2% |
| Unknown | 17 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2022.
All research outputs
#6,848,316
of 22,957,478 outputs
Outputs from Journal of Hematology & Oncology
#463
of 1,194 outputs
Outputs of similar age
#78,783
of 263,349 outputs
Outputs of similar age from Journal of Hematology & Oncology
#8
of 23 outputs
Altmetric has tracked 22,957,478 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,194 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,349 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.